Amadeus trial: Tumor agnostic pre- and ontreatment biomarkers of response to nivolumab plus ipilimumab correlate with ontreatment tumoral T cell infiltration Meeting Abstract


Authors: Alayli, F.; Okrah, K.; Tsimberidou, A.; Drakaki, A.; Khalil, D.; Khan, S.; Hodi, S.; Oh, D.; Amouzgar, M.; Guatam, S.; Kageyama, R.; Pfeiffer, S.; Meier, S.; Cabanski, C.; Da Silva, D.; Kumar, D.; Santulli-Marotto, S.; Tetzlaff, M.; Foo, W. C.; Hollman, T.; Li, Y.; Adamow, M.; Wong, P.; Spasic, M.; Chen, R.; Bucktrout, S.; Fairchild, J.; Butterfield, L.; LaVallee, T.; Padron, L.; Salvador, L.; O'Donnell-Tormey, J.; Dugan, U.; Sharma, P.
Abstract Title: Amadeus trial: Tumor agnostic pre- and ontreatment biomarkers of response to nivolumab plus ipilimumab correlate with ontreatment tumoral T cell infiltration
Meeting Title: 37th Annual Meeting & Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2022)
Journal Title: Journal for ImmunoTherapy of Cancer
Volume: 10
Issue: Suppl. 2
Meeting Dates: 2022 Nov 8-12
Meeting Location: Boston, MA
ISSN: 2051-1426
Publisher: Biomed Central Ltd  
Date Published: 2022-11-01
Start Page: A614
Language: English
ACCESSION: WOS:000919423400550
DOI: 10.1136/jitc-2022-SITC2022.0587
PROVIDER: wos
Notes: Meeting Abstract: 587 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Phillip Wong
    80 Wong
  2. Yanyun Li
    44 Li
  3. Matthew J Adamow
    24 Adamow
  4. Travis Jason Hollmann
    126 Hollmann